In the PC transplantation model, gemcitabine can reduce the protein levels of VEGF, VEGFR2, platelet and endothelial cell adhesion molecule 1 (CD31, PECAM1) and HIF-1α to reduce blood vessel formation, thereby reducing tumor growth 364. The gene discussed is VEGFA; the disease is neoplasm.